MARIANA TAYLOR: Open Payments
NPI 1326636689 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 19 payments from 9 companies in 2025. Trend: 2023 $213 · 2024 $13 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67 |
| Amgen Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $54 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| PFIZER INC. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Abbott Laboratories | 1 | $14 |
Products named: JARDIANCE, QULIPTA, UBRELVY, GVOKE HYPOPEN, REPATHA, OTEZLA, ELIQUIS, Wegovy.
Industry payments across IN — which companies pay providers there.
